26
Participants
Start Date
May 5, 2021
Primary Completion Date
September 5, 2022
Study Completion Date
September 5, 2022
Dulaglutide
Dulaglutide: first week 1x 1.5mg in 0.5 ml, following 3 weeks 2 x 1.5 mg weekly in 0.5ml each, via Pen s.c.
Placebo
Placebo: first week 1x0.5 ml physiological saline (0.9% sodium chloride) injection s.c. via syringe, following weeks 2x0.5 ml physiological saline (0.9% sodium chloride) injection s.c. via syringe once weekly for 3 further weeks.
University Hospital Basel, Endocrinology, Diabetes and Metabolism, Basel
Swiss National Science Foundation
OTHER
Goldschmidt-Jacobson Foundation
UNKNOWN
University Hospital, Basel, Switzerland
OTHER